InterventionsHumans5 yearsCohort study

Effects of Glucagon-Like Peptide-1 Receptor Agonist Use After Transient Ischemic Attack on Risks of Subsequent Ischemic Stroke and Mortality

Journal of Clinical Neurology

The paper